Immuneering-logo (1).png
Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity
March 05, 2023 18:30 ET | Immuneering Corporation
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS mutation Phase 1/2a clinical trial with IMM-1-104 underway in patients with advanced solid...
nsCanary™ Featured on AGA Shark Tank
NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
March 02, 2023 10:00 ET | NovaScan
Chicago, IL, March 02, 2023 (GLOBE NEWSWIRE) -- NovaScan, a clinical stage oncology company, has been selected by the American Gastroenterological Association (AGA) as a finalist in its annual Shark...
Vantage Market Research.png
Cancer Biomarkers Market to Hit USD 31.8 Billion by 2028 | Cancer Biomarkers Industry CAGR 17.5% During 2022-2028; Exclusive Insight Report by Vantage Market Research
May 29, 2022 22:13 ET | Vantage Market Research
WASHINGTON, May 29, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Cancer Biomarkers Market finds that the rise in prevalence of various types of cancers such as...
Straits Research Pvt Ltd
Global Cancer Stem Cells Market is Expected to Reach USD 5.6 Billion by 2030, at a CAGR of 15.8%: Straits Research
May 11, 2022 12:30 ET | Straits Research
New York, United States, May 11, 2022 (GLOBE NEWSWIRE) -- The Global market for cancer stem cells is expected to grow from $ 1.8 Billion in 2021 to $5.6 Billion by 2030, at a compound annual growth...
researchdrivelogo.jpg
Global Cancer Stem Cells Market Estimated to Surpass $1,722.7 Million by 2026, and Grow at a CAGR of 10.3% during the Forecast Period [180-Pages] | Confirmed by Research Dive
April 20, 2022 09:00 ET | Research Dive
New York, USA, April 20, 2022 (GLOBE NEWSWIRE) -- Research Dive states that the global cancer stem cells market is estimated to garner a revenue of $1,722.7 million by 2026, and rise at a CAGR of...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
April 20, 2022 07:00 ET | FibroGen, Inc.
- 356 IPF Patients Enrolled - - Topline Data Anticipated Mid-2023 - SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced completion of patient...
Noah_Medical_logo_MASTER.jpg
Noah Medical Announces New Research and Training Facilities for Next Generation Medical Robotics Platforms
March 09, 2022 08:00 ET | Noah Medical
SAN CARLOS, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today unveiled a new 10,000 square foot research and training facility in Sunnyvale, California and a...
TIP_link_300x300.jpg
Acute Lung Injury Market Size to Outstrip $741.98Mn by 2028 Growth Projections at 4.7% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
September 28, 2021 11:09 ET | The Insight Partners
New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Acute Lung Injury Market: Key InsightsAccording to our new research study on "Acute Lung Injury Market to 2028 – Global Analysis and Forecast – by...
researchdrivelogo.jpg
Global Cancer Stem Cells Market to Surpass $1,898.3 Million, Growing with a CAGR of 11.8% from 2019 to 2026, Post-COVID-19 Disaster by Research Dive
August 17, 2021 09:02 ET | Research Dive
New York, USA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- A newest report on the global cancer stem cells market has been added by Research Dive to its repository. The report presents exhaustive insights on...
researchdrivelogo.jpg
Global Cancer Stem Cells Market to Witness Exponential Growth Owing to the Rising Efficiency of Stem Cell Therapy – Informative Report [180 Pages] by Research Dive
August 02, 2021 09:00 ET | Research Dive
New York, USA, Aug. 02, 2021 (GLOBE NEWSWIRE) -- A recently published report by Research Dive states that the global cancer stem cells market is expected to witness a rise in revenue from $786.3...